No-Cost, No-Obligation Zantac Cancer Attorney Case Review

Antacid Cancer Attorney
Zantac Lawsuit News

Zantac and Generic Ranitidine Heartburn Medicine Recalled Because of Cancer Link

Zantac has garnered headlines leading to all generic ranitidine medications being recalled

Monday, July 13, 2020 - The world's best-selling Heartburn and acid-reflux medicine Zantac was recalled over concerns that it is chemically unstable and could cause stomach, bladder, intestinal, and many other forms of cancer. Thousands of cancer sufferers or the estates of those who have died have consulted a Zantac Cancer Lawyer have or expected to file lawsuits against Sanofi, the maker of the drug for failing to warn consumers of what they knew or had a responsibility to know about the drug's high NDMA defect. The number of lawsuits could grow into substantial personal injury litigation in 2020 and beyond as plaintiffs allege that Sanofi purposefully hid the drug's alleged cancer-causing complications. Others are suffering in the wake of the Zantac recall in addition to those who are suffering from cancer.

Millions of heartburn sufferers are no longer able to find their preferred acid reflux relief drug, and are also afraid to take Zantac's alternatives over concerns about protein pump inhibitor drugs (PPIs) may increase a person's risk of developing severe symptoms from the Coronavirus. Stomach acids kill unwanted bacteria and viruses, and heartburn drugs block the production of stomach acid.

On April 1, 2020, the US Food and Drug Administration (FDA) took decisive action to prevent the use or prescription of the entire class of ranitidine heartburn medications. The American Journal of Managed Care writes. "The FDA has requested all ranitidine (Zantac) products be pulled from the market immediately, according to a statement. The recall includes all prescription and over-the-counter ranitidine drugs as ongoing investigations uncovered levels of N-Nitrosodimethylamine (NDMA), a probable human carcinogen, increase over time." In addition to popular brand name drugs like Zantac, Pepcid, and Prilosec that have garnered media attention, other generic ranitidine heartburn drugs have been recalled and their prescription forbidden in the FDA's most recent directive.

Over the counter drug manufacturer, Apotex Corp. has recalled all of their generic 75 mg and 150 mg ranitidine tablets sold in retail pharmacies Walgreens, Walmart and Rite-Aid over the fear that high storage temperatures could cause ranitidine to become unstable and increase the levels of NDMA, a known carcinogen. According to an investigative report at KXAN Austin, other ranitidine manufacturers that have pulled their generic heartburn medicines include, "Novartis-owned Sandoz recall(ing their) 30-count, 50-count and 500-count bottles of prescription ranitidine capsules, and overseas, British drugmaker GlaxoSmithKline, recalling ranitidine products in India and Hong Kong (it does not sell versions of the drug in the US). Several countries are taking steps to restrict sales of drugs containing ranitidine." The FDA has a complete list on their website which includes the following generic ranitidine tablets: all sizes of USP 150mg- acid reducer sold at Rite Aid and Walmart, and Walgreen's, "Wal-Zan 150 RANITIDINE TABLETS, USP 150 mg / ACID REDUCER."

If you or a loved one have taken Zantac regularly and has developed stomach, bladder, prostate, esophageal, intestinal, colon, breast, liver, or other cancer, you may qualify to file a claim against Sanofi, the drug's manufacturer.

More Recent Heartburn MedicineLawsuit News:

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.